Clinical Trial: Pharmacokinetics, Safety, Tolerability and Efficacy of a Subcutaneous Long-Acting Injection of Cariprazine (Cariprazine Depot) in Subjects Eligible for Treatment With Oral Cariprazine

U.S., Sept. 23 -- ClinicalTrials.gov registry received information related to the study (NCT07185815) titled 'Pharmacokinetics, Safety, Tolerability and Efficacy of a Subcutaneous Long-Acting Injection of Cariprazine (Cariprazine Depot) in Subjects Eligible for Treatment With Oral Cariprazine' on Aug. 28.

Brief Summary: The purpose of this study is to assess the PK, Safety, Tolerability (all cohorts) and Efficacy (cohort 3), of once-a-month long-acting SC injection of dose escalating Cariprazine Depot in subjects eligible for treatment with oral Cariprazine.

Study Start Date: Aug. 01

Study Type: INTERVENTIONAL

Condition: Major Depressive Disorder (MDD) Bipolar 1 Disorder Schizophrenia

Intervention: DRUG: Cariprazine Depot

One single...